XML 23 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Business Acquisition, Contingent Consideration [Line Items]      
Increased in net loss resulted from change in discount rate $ 3,600,000    
Increased in net loss per share resulted from change in discount rate $ 0.22    
Increase (decrease) on change in fair value of contingent consideration liability 39,913,000 (1,900,000) 4,000,000
Increased in net loss resulted from change in assumptions 39,913,000    
Estimated fair value of financing obligations 9,342,000 6,254,000  
Book values of financing obligations 11,524,000 6,461,000  
Maturity period of highly liquid investments Three months or less    
Uncertain tax position recognition likelihood percentage 50.00%    
Grupo Ferrer Internacional, S.A. [Member]
     
Business Acquisition, Contingent Consideration [Line Items]      
Increase (decrease) on change in fair value of contingent consideration liability     4,000,000
Increase (decrease) in earnings per share     $ 0.59
Upfront cash received under collaborative arrangement   10,000,000  
Upfront cash received under collaborative arrangement 1,250,000    
Grupo Ferrer Internacional, S.A. [Member] | Allegro stockholders [Member]
     
Business Acquisition, Contingent Consideration [Line Items]      
Payments to former stockholders under collaborative arrangement 312,500 5,000,000  
No collaboration partner [Member]
     
Business Acquisition, Contingent Consideration [Line Items]      
Increase (decrease) in earnings per share   $ 0.15  
Teva Pharmaceuticals USA, Inc. [Member]
     
Business Acquisition, Contingent Consideration [Line Items]      
Increase (decrease) in earnings per share $ 2.39    
Upfront cash received under collaborative arrangement 40,000,000    
Teva Pharmaceuticals USA, Inc. [Member] | Allegro stockholders [Member]
     
Business Acquisition, Contingent Consideration [Line Items]      
Payments to former stockholders under collaborative arrangement $ 10,313,000    
Maximum [Member]
     
Business Acquisition, Contingent Consideration [Line Items]      
Cash flow discount rate 18.00%    
Minimum [Member]
     
Business Acquisition, Contingent Consideration [Line Items]      
Cash flow discount rate 16.50%